Literature DB >> 12351536

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters.

Maryse Bonduelle1, Elvire Van Assche, Hubert Joris, Kathelijn Keymolen, Paul Devroey, André Van Steirteghem, Inge Liebaers.   

Abstract

BACKGROUND: Prenatal testing was offered in all pregnancies obtained after ICSI with ejaculated or non-ejaculated sperm as part of the evaluation of the safety of ICSI.
METHODS: Between 1990 and 2001, a chorionic villus sampling (CVS) or amniocentesis was offered for multiple or singleton pregnancies respectively during a genetic counselling session for all couples applying for ICSI. ICSI was carried out using ejaculated, epididymal or testicular sperm.
RESULTS: In total, 1586 ICSI fetuses obtained after fresh embryo transfer were tested by CVS (n = 698) or by amniocentesis (n = 888). Abnormal fetal karyotypes were found in 47 samples [3.0%; 95% confidence interval (CI) 2.2-3.9%]; 25 anomalies (1.6%; 95% CI 1.0-2.3%) were de novo. These were 10 sex chromosomal anomalies and 15 autosomal anomalies [either numerical (n = 8) or structural (n = 7)], and 22 inherited abnormalities (1.4%; 95% CI 0.9-2.1%) (21 balanced, one unbalanced). In 17/22 inherited cases the chromosomal structural defect was inherited from the father. A significantly higher percentage of 2.1% de-novo prenatal chromosomal anomalies was observed for sperm concentrations of <20x10(6) sperm per ml, as compared with 0.24% if the sperm concentration was vertical line 20x10(6) sperm per ml (Fisher's exact test, P = 0.006). No statistical difference in frequency of chromosomal anomalies was observed for lower threshold values of sperm concentration (<1x10(6), <5x10(6), <10x10(6) and <15x10(6)). A statistical difference was observed for motility criteria, but not morphology. Three chromosomal anomalies were found prenatally after use of epididymal or testicular sperm in a total of 94 samples; two (of 83 tested) were from patients with obstructive and one (of nine tested) was from a patient with non-obstructive azoospermia.
CONCLUSIONS: A significantly higher rate of de-novo chromosomal anomalies (1.6 versus 0.5% in amniocentesis for a mean maternal age of 33.5 years; P < 0.007) was observed in ICSI offspring, relating mainly to a higher number of sex chromosomal anomalies and partly to a higher number of autosomal structural anomalies. This finding was related to sperm concentration and motility. The significantly higher rate of observed inherited anomalies (1.4 versus 0.3-0.4% in prenatal tests in the general population; P < 0.001) was related to a higher rate of constitutional chromosomal anomalies, mainly in the fathers. The hypothesis of a higher risk of post-zygotic events as a consequence of the ICSI procedure leading to a higher proportion of chromosomal mosaicism was not confirmed in this study. Couples should be informed of the risks of an abnormal result related to sperm quality, and of the risk linked to a prenatal procedure as well as about the relatively benign character of some chromosomal anomalies such as de-novo structural anomalies or sex chromosomal anomalies in order to be able to make a choice for prenatal testing, or not.

Entities:  

Mesh:

Year:  2002        PMID: 12351536     DOI: 10.1093/humrep/17.10.2600

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  54 in total

1.  Clinical evaluation of the infertile male: new options, new challenges.

Authors:  Robert I McLachlan; Csilla Krausz
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

2.  Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation.

Authors:  Yue-hong Lu; Hui-juan Gao; Bai-jia Li; Ying-ming Zheng; Ying-hui Ye; Yu-li Qian; Chen-ming Xu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

3.  Assisted reproductive technologies do not alter mutation frequency or spectrum.

Authors:  Lee Caperton; Patricia Murphey; Yukiko Yamazaki; C Alex McMahan; Christi A Walter; Ryuzo Yanagimachi; John R McCarrey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

Review 4.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

Review 5.  Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?

Authors:  Kim Dao Ly; Ashok Agarwal; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2011-07-09       Impact factor: 3.412

6.  Subclinical pregnancy losses among women undergoing in-vitro fertilization with ICSI.

Authors:  Ulun Ulug; Suleyman Tosun; Esra Aksoy Jozwiak; Ali Mesut; Alper Sismanoglu; Mustafa Bahceci
Journal:  J Assist Reprod Genet       Date:  2006-08-01       Impact factor: 3.412

7.  Comparison of chromosomal abnormality rates in ICSI for non-male factor and spontaneous conception.

Authors:  Banu Bingol; Faruk Abike; Ali Gedikbasi; Omer Lutfi Tapisiz; Ziya Gunenc
Journal:  J Assist Reprod Genet       Date:  2011-10-25       Impact factor: 3.412

8.  Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins.

Authors:  Richard S Legro; Michael P Diamond; Christos Coutifaris; William D Schlaff; Ruben Alvero; Peter Casson; Gregory M Christman; R Mitchell Rosen; Marcelle I Cedars; Karl R Hansen; Randal Robinson; Valerie Baker; Rebecca Usadi; William C Dodson; Stephanie J Estes; Allen Kunselman; Christina Stetter; Kurt T Barnhart; R Matthew Coward; J C Trussell; Stephen A Krawetz; Nanette Santoro; Hao Huang; Heping Zhang; Esther Eisenberg
Journal:  Fertil Steril       Date:  2020-05       Impact factor: 7.329

9.  Chromosomal abnormalities in spontaneous abortion after assisted reproductive treatment.

Authors:  Ji Won Kim; Woo Sik Lee; Tae Ki Yoon; Hyun Ha Seok; Jung Hyun Cho; You Shin Kim; Sang Woo Lyu; Sung Han Shim
Journal:  BMC Med Genet       Date:  2010-11-03       Impact factor: 2.103

10.  Low-level gonosomal mosaicism in women undergoing ICSI cycles.

Authors:  R Voigt; A K Schröder; E Hinrichs; K Diedrich; E Schwinger; M Ludwig
Journal:  J Assist Reprod Genet       Date:  2004-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.